openPR Logo
Press release

Biomaterials Market Worth $64.2 billion | MarketsandMarkets™

04-25-2024 09:02 AM CET | Health & Medicine

Press release from: MarketsandMarkets

Biomaterials Market

Biomaterials Market

Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing demand for biomaterials in wound healing and plastic surgery and the growing use of biomaterials in various therapeutic areas. Rising funding and investments in regenerative and personalized medicine and growing demand for implantable devices are expected to drive market growth in the near future.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=393&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

Metallic biomaterials segment accounted for the largest estimated share of the biomaterials market

Based on type, the biomaterials market is segmented into metallic (stainless steel, titanium & titanium alloys, cobalt-chrome alloys, gold, silver, magnesium, and other metallic biomaterials), polymeric (polymethylmethacrylate, polyethylene, polyester, polyvinylchloride, silicone rubber, nylon, , other polymeric biomaterials), ceramic (calcium phosphate, zirconia, aluminum oxide, calcium sulfate, carbon and glass) and natural (hyaluronic acid, collagen, fibrin, cellulose, chitin, alginate, gelatin, chitosan, silk, other natural biomaterials). The metallic biomaterials segment was predicted to account for the largest share of the biomaterials market in 2023. The dominant share of this segment can primarily be attributed to the wide use of metals in the manufacturing of medical devices for cardiovascular, dental, and orthopedic applications. The growing geriatric population globally is also expected to increase the demand for these devices as age increases the susceptibility to orthopedic, dental, ophthalmological, neurological, and cardiovascular disorders.

Orthopedic applications win the largest estimated share of therapeutic areas

Based on application, the biomaterials market is classified into Cardiovascular (Catheters, Stents, Implantable Cardiac Defibrillators, Sensors, Heart Valves, Vascular Grafts, Guidewires, Other Cardiovascular Products), Orthopedic (Joint Replacement [Knee Replacement, Hip Replacement, Shoulder Replacement, Other Joint Replacement Procedures], Spine Surgery, [Spinal Fusion, Minimally Invasive Fusion, Motion Preservation & Dynamic Stabilization {Pedicle-based Rod Systems, Interspinous Spacers, Artificial Discs}], Bioresorbable Tissue Fixation [Suture Anchors, Interference Screws, Meniscal Repair Tacks, Meshes], Orthobiologics, Fracture Fixation [Bone Plates, Screws, Pins, Rods, Wires]), Ophthalmology (Contact Lenses, Intraocular Lenses, Functional Replacement of Ocular Tissues, Synthetic Corneas, Other Ophthalmology Products), Dental (Dental Implants, Dental Bone Grafts & Substitutes, Dental Membranes, Tissue Regeneration Materials), Plastic Surgery (Soft Tissue Fillers, Craniofacial Surgery Products, Facial Wrinkle Treatment Devices, Bioengineered Skins, Peripheral Nerve Repair Devices, Acellular Dermal Matrices), Wound Healing (Wound Closure Devices, [Sutures, Staples] Internal Tissue Sealants, Surgical Hemostats, Adhesion Barriers, Hernia Meshes, Skin Substitutes), Tissue Engineering (Scaffolds, Nanomaterials, Inorganic Nanoparticles), Neurological/Central Nervous System, (Shunting Systems, Cortical Neural Prosthetics, Hydrogel Scaffolds, Neural Stem Cell Encapsulation Products), Urinary (Urinary Catheters, Urethral Stents, Other Urinary Products) and Other Applications (Drug Delivery Systems, Gastrointestinal, Bariatric Surgery). In 2023, the orthopedic segment was predicted to account for the largest share of the global biomaterials market. The large share of this application segment can be attributed to the increasing prevalence of orthopedic conditions, such as osteoarthritis, osteoporosis, and musculoskeletal injuries. Additionally, advancements in biomaterial technologies have led to the development of innovative materials with enhanced biocompatibility, durability, and mechanical properties, thereby expanding their applications in orthopedic surgeries and treatments.

During the forecast period, North America exhibited the most rapid growth.

North America accounted for the largest share of 40.2% of the global biomaterials market, followed by Europe and the Asia Pacific, with shares of 31.5% and 21.4%, respectively. The increase in biomaterial-based research, the rising demand for plastic surgeries, the growing incidence of cancer, and the rising prevalence of cardiovascular diseases are the key factors driving the growth of this market. The market in the Asia Pacific is expected to witness the highest growth rate of 7.7% during the forecast period, primarily due to the rising geriatric population in China and India, the growing healthcare industry in Japan, and the rising prevalence of cardiovascular diseases in India.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=393&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

Key Market Players of Biomaterials Industry:

The global biomaterials market comprises of many key market players competing for markets shares like BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Carpenter Technology Corporation (US), DSM (Netherlands), Corbion NV (Netherlands), Evonik Industries AG (Germany), Victrex Plc (UK), CeramTec GmbH (Germany), Mitsubishi Chemical Group Corporation (Japan), CoorsTek Inc. (US), Berkeley Advanced Biomaterials (US), CAM Bioceramics B.V. (Netherlands), Zeus Company Inc. (US), AMETEK Inc. (US), and GELITA AG (Germany).

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 80%, and Demand Side - 20%
By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, MEA- 5%
Recent Developments of Biomaterials Industry:

In October 2022, BASF launched two new sustainable product families: Ultraform LowPCF (Low Product Carbon Footprint) and Ultraform BMB (Biomass Balance) to support the sustainability goals of the customer. BASF has designated Ultraform as its trademark for the polyoxymethylene (POM) portfolio. Ultraform LowPCF presents a Product Carbon Footprint that surpasses conventional Ultraform grades by a minimum of 30% through the utilization of green electricity and the implementation of energy-efficient technology.
In February 2023, Covestro launched Makrolon 3638 polycarbonate for use in both healthcare and life science applications. This polycarbonate grade is durable, with the ability to withstand everyday use while maintaining structural integrity.
In September 2022, Celanese Corporation entered into a strategic agreement with polymer distributor Ravago for Celanese's Santoprene and Geolast TPV portfolio in North American countries, such as the US, Canada, and Mexico.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=393&utm_source=Openpr&utm_campaign=Paid&utm_content=Referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insights: https://www.marketsandmarkets.com/ResearchInsight/biomaterial-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/global-biomaterials.asp

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biomaterials Market Worth $64.2 billion | MarketsandMarkets™ here

News-ID: 3474908 • Views:

More Releases from MarketsandMarkets

Laser Interferometer Market Set to Grow at the Fastest Rate- Time to Grow your Revenue
Laser Interferometer Market Set to Grow at the Fastest Rate- Time to Grow your R …
The global laser interferometer market is expected to be valued at 315 million in 2024 and is projected to reach USD 447 million by 2029, at a CAGR of 7.2% from 2024 to 2029. Emerging applications in industries push the market's growth due to the growing demand for precision in the manufacturing sector. However, challenges such as higher initial investments and maintenance costs cause problems. Despite these, opportunities arise for
With 19.6% CAGR, Battery Testing, Inspection, and Certification Market Growth to Surpass USD 36.7 billion
With 19.6% CAGR, Battery Testing, Inspection, and Certification Market Growth to …
The battery testing, inspection, and certification market is projected to reach USD 36.7 billion by 2029 from USD 14.9 billion in 2024 at a CAGR of 19.6% during the forecast period. Increasing adoption of EVs and energy storage systems, rising enforcement of stringent standards to ensure battery safety, thriving portable electronics industry, and rapid advances in battery technology are the major factors contributing to the market growth. Download PDF Brochure @
Real-Time Location Systems Revolutionize Healthcare: Insights from MarketsandMarkets
Real-Time Location Systems Revolutionize Healthcare: Insights from MarketsandMar …
The global RTLS market for healthcare is projected to grow from USD 2.3 billion in 2024 to USD 5.7 billion by 2029, at a compound annual growth rate of 19.6% from 2024 to 2029. As it attracts more and more players who enter this market with innovative RTLS features for customers, the market for RTLS technology is rapidly increasing. Top companies in this market focus on healthcare, retail, and manufacturing
Offsite Data Center Power Infrastructure Market Size to Reach $35.4 billion by 2030 | Leading key players are ABB, Schneider Electric, Eaton, Vertiv
Offsite Data Center Power Infrastructure Market Size to Reach $35.4 billion by 2 …
According to a research report "Offsite Data Center Power Infrastructure Market by Component (Solutions and Services), Vertical (BFSI, Media & Entertainment, Government & Defence, Healthcare, Manufacturing, IT & Telecom, Retail) and Region - Global Forecast to 2030" published by MarketsandMarkets, the market size for global offsite data center power infrastructure market is projected to reach approximately USD 35.4 billion by the year 2030, as compared to the estimated value of

All 5 Releases


More Releases for Biomaterials

Biomaterials: Core Growth Enabler in the Rising Incidence Of Cardiovascular Dise …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. What Will the Biomaterials Industry Market Size Be by 2025? The biomaterials industry has seen a swift expansion in its market size in recent years. The market is projected to climb from $134.31 billion in 2024 to $153.55 billion in 2025, advancing at a compound annual growth rate (CAGR) of 14.3%. The historic growth
Uncovering Biomaterials Market Dynamics
The biomaterials market size is expected to be valued at USD 144.9 Billion in 2024 and reach USD 285.3 Billion by 2029, growing at a CAGR of 14.5 % from 2024 to 2029. Biomaterials are substances engineered to interact with biological systems for medical purposes, either therapeutic or diagnostic. They play a crucial role in medicine by restoring function and facilitating healing for people after injury or disease. Biomaterials are natural
Natural Biomaterials Market Ongoing Trends and Recent Developments | Key Players …
This detailed market study covers natural biomaterials market growth potentials which can assist the stake holders to understand key trends and prospects in natural biomaterials market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. The
Biomaterials Market 2019 Growth Opportunities: DSM, Zimmer Biomet, DePuy Synthes …
The Biomaterials market is anticipated to grow in the forecast, owing to the factors such as rising geriatric population, increasing prevalence of cardiovascular, neurological and orthopedic disorders, heavy funding by government organizations to launch novel products, rising awareness regarding the advantages of biomaterial products and advancements in technology. The Biomaterials Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints
Natural Biomaterials Market Opportunity Analysis, 2018–2026: BASF SE, Biomet, …
Biomaterials have gained tremendous attention in tissue engineering and regenerative medicine applications attributing to their ability to enhance functional tissue regeneration. Biomaterial can be categories into natural biomaterials and synthetic biomaterials. Natural biomaterials offer various advantages over synthetic biomaterials such as they already have binding sites for cells and adhesion molecules so the biocompatibility is not a major issue. On account of advantages offered, the demand for natural biomaterials is
Natural Biomaterials Market Industry Analysis 2026: BASF SE, Biomet, Inc., Invib …
Biomaterials have gained tremendous attention in tissue engineering and regenerative medicine applications attributing to their ability to enhance functional tissue regeneration. Biomaterial can be categories into natural biomaterials and synthetic biomaterials. Natural biomaterials offer various advantages over synthetic biomaterials such as they already have binding sites for cells and adhesion molecules so the biocompatibility is not a major issue. On account of advantages offered, the demand for natural biomaterials is